Insulet (PODD) EPS (Weighted Average and Diluted) (2016 - 2025)
Insulet's EPS (Weighted Average and Diluted) history spans 10 years, with the latest figure at $1.43 for Q4 2025.
- For Q4 2025, EPS (Weighted Average and Diluted) rose 3.62% year-over-year to $1.43; the TTM value through Dec 2025 reached $3.49, down 39.62%, while the annual FY2025 figure was $3.48, 39.79% down from the prior year.
- EPS (Weighted Average and Diluted) reached $1.43 in Q4 2025 per PODD's latest filing, up from $1.24 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.59 in Q2 2024 to a low of -$0.5 in Q2 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.66, with a median of $0.42 recorded in 2021.
- Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 268.18% in 2021, then skyrocketed 1025.0% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.42 in 2021, then crashed by 40.48% to $0.25 in 2022, then surged by 488.0% to $1.47 in 2023, then dropped by 6.12% to $1.38 in 2024, then increased by 3.62% to $1.43 in 2025.
- Per Business Quant, the three most recent readings for PODD's EPS (Weighted Average and Diluted) are $1.43 (Q4 2025), $1.24 (Q3 2025), and $0.32 (Q2 2025).